TY - JOUR
T1 - Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families
AU - Grabowski, Monika
AU - Mueller-Koch, Yvonne
AU - Grasbon-Frodl, Eva
AU - Koehler, Udo
AU - Keller, Gisela
AU - Vogelsang, Holger
AU - Dietmaier, Wolfgang
AU - Kopp, Reinhard
AU - Siebers, Ulrike
AU - Schmitt, Wolfgang
AU - Neitzel, Birgit
AU - Gruber, Maria
AU - Doerner, Christa
AU - Kerker, Brigitte
AU - Ruemmele, Petra
AU - Henke, Gabriele
AU - Holinski-Feder, Elke
PY - 2005
Y1 - 2005
N2 - Hereditary nonpolyposis colorectal cancer (HNPCC) is due to defects in DNA mismatch repair (MMR) genes MSH2, MLH1, MSH6, and to a lesser extent PMS2. Of 466 suspected HNPCC families, we defined 54 index patients with either tumors of high microsatellite instability (MS1-H) and/or loss of expression for either MLH1, MSH2, and/or MSH6, but without a detectable pathogenic point mutation in these genes. This study cohort was augmented to 64 patients by 10 mutation-negative index patients from Amsterdam families where no tumors were available. Deletion/duplication screening using the multiplex ligation-dependent probe amplification (MLPA) revealed 12 deletions in MSH2 and two deletions in MLH1. These deletions constitute 17% of pathogenic germline alterations but elucidate the susceptibility to HNPCC in only 22% of the mutation-negative study cohort, pointing towards other mutation mechanisms for an inherited inactivation of MLH1 or MSH2. We describe here four novel deletions. One novel and one known type of deletion were found for three and two unrelated families, respectively. MLPA analysis proved a reliable method for the detection of genomic deletions in MLH1 and MSH2; however, sequence variations in the ligation-probe binding site can mimic single exon deletions.
AB - Hereditary nonpolyposis colorectal cancer (HNPCC) is due to defects in DNA mismatch repair (MMR) genes MSH2, MLH1, MSH6, and to a lesser extent PMS2. Of 466 suspected HNPCC families, we defined 54 index patients with either tumors of high microsatellite instability (MS1-H) and/or loss of expression for either MLH1, MSH2, and/or MSH6, but without a detectable pathogenic point mutation in these genes. This study cohort was augmented to 64 patients by 10 mutation-negative index patients from Amsterdam families where no tumors were available. Deletion/duplication screening using the multiplex ligation-dependent probe amplification (MLPA) revealed 12 deletions in MSH2 and two deletions in MLH1. These deletions constitute 17% of pathogenic germline alterations but elucidate the susceptibility to HNPCC in only 22% of the mutation-negative study cohort, pointing towards other mutation mechanisms for an inherited inactivation of MLH1 or MSH2. We describe here four novel deletions. One novel and one known type of deletion were found for three and two unrelated families, respectively. MLPA analysis proved a reliable method for the detection of genomic deletions in MLH1 and MSH2; however, sequence variations in the ligation-probe binding site can mimic single exon deletions.
UR - http://www.scopus.com/inward/record.url?scp=21044452350&partnerID=8YFLogxK
U2 - 10.1089/gte.2005.9.138
DO - 10.1089/gte.2005.9.138
M3 - Article
C2 - 15943554
AN - SCOPUS:21044452350
SN - 1090-6576
VL - 9
SP - 138
EP - 146
JO - Genetic Testing
JF - Genetic Testing
IS - 2
ER -